| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Andrew Aronsohn | |
| Donald Jensen | |||
| P2860 | cites work | Hepatitis C virus: epidemiology and genotypes in the north east of England. | Q27473017 |
| Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 | ||
| Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients | Q28274666 | ||
| Diagnosis, management, and treatment of hepatitis C: an update | Q29619682 | ||
| Telaprevir for retreatment of HCV infection | Q29619799 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Boceprevir for untreated chronic HCV genotype 1 infection | Q29620617 | ||
| A review of the treatment of chronic hepatitis C virus infection in cirrhosis | Q33394104 | ||
| Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial. | Q37126762 | ||
| Managing pediatric hepatitis C: current and emerging treatment options | Q37316248 | ||
| Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus | Q37849720 | ||
| Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C. | Q38376150 | ||
| Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. | Q42651816 | ||
| Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection | Q42947251 | ||
| Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials | Q42990077 | ||
| Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: a controlled study. | Q43033959 | ||
| Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group | Q43036483 | ||
| A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation | Q43038824 | ||
| Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection | Q45738786 | ||
| Outcomes of acute rejection after interferon therapy in liver transplant recipients | Q47240318 | ||
| Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective study | Q72991317 | ||
| Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C | Q83763566 | ||
| Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus | Q84208214 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 20-23 | |
| P577 | publication date | 2012-02-01 | |
| P1433 | published in | Clinical liver disease | Q27726171 |
| P1476 | title | The long-term horizon: Patients who will remain untreated in the era of triple therapy | |
| P478 | volume | 1 |
| Q92669690 | Hepatitis C viral infection in incarcerated patients | cites work | P2860 |
Search more.